Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label of. Show all posts
Showing posts with label of. Show all posts
Tuesday, July 7, 2026

FDA Approves Icotyde (icotrokinra) for the Treatment of Plaque Psoriasis

›
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved Icotyde (icotrokinra), an in...
Tuesday, June 30, 2026

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

›
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmace...
Tuesday, June 16, 2026

Lilly's announces results from Phase III clinical trial of Jaypirca

›
In continuation of my update on  pirtobrutinib Eli Lilly and Company announced results from the Phase 3 BRUIN CLL-322 clinical trial of Jayp...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.